...
首页> 外文期刊>Pediatric cardiology >Predictors of Prolonged Hospital Length of Stay Following Stage II Palliation of Hypoplastic Left Heart Syndrome (and Variants): Analysis of the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) Database
【24h】

Predictors of Prolonged Hospital Length of Stay Following Stage II Palliation of Hypoplastic Left Heart Syndrome (and Variants): Analysis of the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) Database

机译:发育不良左心综合征(及其变种)II期姑息治疗后住院时间延长的预测因素:美国国家小儿心脏病学质量改进协作组织(NPC-QIC)数据库的分析

获取原文
获取原文并翻译 | 示例

摘要

The objective of this study is to identify predictors of prolonged hospital length of stay (LOS) for single ventricle patients following stage 2 palliation (S2P), excluding patients who underwent a hybrid procedure. We explore the impact of demographic features, stage 1 palliation (S1P), interstage I (IS1) management, S2P, and post-surgical care on hospital LOS following S2P. We conducted a retrospective analysis of the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) database. The NPC-QIC database is an established registry of patients with hypoplastic left heart syndrome (HLHS) and its variants. It contains detailed information regarding the demographic features, S1P, IS1, S2P, and interstage 2 (IS2) management of children with HLHS and related single ventricle cardiac malformations. Between 2008 and 2012, there were 477 participants with recorded LOS data in the NPC-QIC registry. Excluding the 29 patients who underwent hybrid procedure, there were 448 participants who underwent a Norwood (or Norwood-variant procedure) as S1P. In order to be included in the NPC-QIC database, participants were discharged to home following S1P and prior to S2P. We found that postoperative LOS among the 448 S2P procedure recipients is most strongly influenced by the need for reoperation following S2P, the need for an additional cardiac catheterization procedure following S2P, the use of non-oral methods of nutrition (e.g., nasogastric tube, total parental nutrition, gastrostomy tube), and the development of postoperative complications. Factors such as age at the time of S2P, the presence of a major non-cardiac anomaly, site participant volume, IS1 course, the type and number of vasoactive agents used following S2P, and the need for more than 1 intensive care unit (ICU) hospitalization (following discharge to the ward but prior to discharge to home) were significant predictors by univariate analysis but not by multivariate analysis. We excluded participants undergoing the hybrid procedure as S1P from this analysis given that the S2P following the initial hybrid is typically a more complicated procedure. Hospital LOS following S2P among children undergoing the Norwood or Norwood-variant procedure as S1P is most strongly influenced by events following S2P and not demographic or S1P factors. Factors most predictive of prolonged LOS include the need for reoperation, the need for an additional cardiac catheterization procedure following S2P, the need for non-oral methods of nutrition, and the development of postoperative complications.
机译:这项研究的目的是确定单心室患者2期缓解(S2P)后住院时间延长(LOS)的预测因素,不包括接受混合手术的患者。我们探讨人口统计学特征,第1阶段减轻(S1P),第I阶段间(IS1)管理,S2P和手术后护理对S2P后医院LOS的影响。我们对美国国家小儿心血管病质量改进合作组织(NPC-QIC)数据库进行了回顾性分析。 NPC-QIC数据库是患有发育不良性左心综合征(HLHS)及其变体的患者的既定注册表。它包含有关HLHS及相关单心室心脏畸形儿童的人口统计学特征,S1P,IS1,S2P和2期治疗(IS2)的详细信息。在2008年至2012年之间,有477名参与者在NPC-QIC注册中心中记录了LOS数据。除29位接受混合手术的患者外,有448位接受了Norwood(或Norwood变异手术)作为S1P的参与者。为了包括在NPC-QIC数据库中,参与者在S1P之后和S2P之前已出院回家。我们发现,在448名S2P手术接受者中,术后LOS受S2P手术后再次手术的需要,S2P手术后需要进行额外的心脏导管手术,使用非口服营养方法(例如,鼻胃管,总父母的营养,胃造口术),以及术后并发症的发展。诸如S2P时的年龄,是否存在严重的非心脏异常,现场参与者数量,IS1病程,在S2P之后使用的血管活性剂的类型和数量以及是否需要1个以上的重症监护病房(ICU)等因素住院(出院后但出院前)是单因素分析而非多因素分析的重要预测指标。鉴于初始混合后的S2P通常是一个更复杂的过程,因此从此分析中排除了接受混合过程作为S1P的参与者。在经历Norwood或Norwood-variant程序作为S1P的儿童中,S2P之后的医院LOS受S2P之后事件的影响最大,而不受人口统计学或S1P因素的影响最大。最能预测LOS延长的因素包括再次手术的需要,在S2P之后需要进行额外的心脏导管插入术,需要非口服营养方法以及术后并发症的发生。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号